Syndax Pharmaceuticals Inc·4

Apr 28, 4:15 PM ET

Meyers Michael L. 4

4 · Syndax Pharmaceuticals Inc · Filed Apr 28, 2021

Insider Transaction Report

Form 4
Period: 2021-04-26
Meyers Michael L.
SVP, Chief Development Officer
Transactions
  • Purchase

    Common Stock

    2021-04-26$15.46/sh+500$7,73015,666 total

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT